- Home
- ILPT vs INMB Comparison
ILPT vs INMB Comparison
Compare ILPT & INMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ILPT
- INMB
- Stock Information
- Founded
- ILPT 2017
- INMB 2015
- Country
- ILPT United States
- INMB United States
- Employees
- ILPT N/A
- INMB N/A
- Industry
- ILPT Real Estate Investment Trusts
- INMB Biotechnology: Pharmaceutical Preparations
- Sector
- ILPT Real Estate
- INMB Health Care
- Exchange
- ILPT Nasdaq
- INMB Nasdaq
- Market Cap
- ILPT 174.6M
- INMB 176.5M
- IPO Year
- ILPT 2018
- INMB 2019
- Fundamental
- Price
- ILPT $3.29
- INMB $7.38
- Analyst Decision
- ILPT Buy
- INMB Strong Buy
- Analyst Count
- ILPT 2
- INMB 3
- Target Price
- ILPT $10.00
- INMB $24.33
- AVG Volume (30 Days)
- ILPT 371.9K
- INMB 274.4K
- Earning Date
- ILPT 04-29-2025
- INMB 05-08-2025
- Dividend Yield
- ILPT 1.22%
- INMB N/A
- EPS Growth
- ILPT N/A
- INMB N/A
- EPS
- ILPT N/A
- INMB N/A
- Revenue
- ILPT $441,992,000.00
- INMB $50,000.00
- Revenue This Year
- ILPT $3.09
- INMB N/A
- Revenue Next Year
- ILPT $1.79
- INMB $43,178.43
- P/E Ratio
- ILPT N/A
- INMB N/A
- Revenue Growth
- ILPT 0.61
- INMB N/A
- 52 Week Low
- ILPT $2.45
- INMB $4.32
- 52 Week High
- ILPT $5.45
- INMB $10.50
- Technical
- Relative Strength Index (RSI)
- ILPT 55.89
- INMB 47.48
- Support Level
- ILPT $3.01
- INMB $7.25
- Resistance Level
- ILPT $3.41
- INMB $8.06
- Average True Range (ATR)
- ILPT 0.15
- INMB 0.47
- MACD
- ILPT 0.01
- INMB -0.01
- Stochastic Oscillator
- ILPT 44.44
- INMB 25.45
About ILPT Industrial Logistics Properties Trust of Beneficial Interest
Industrial Logistics Properties Trust is a real estate investment trust. It owns and leases industrial and logistics properties throughout the United States. The company's investment portfolio includes industrial lands in Hawaii and industrial and logistics properties in other states. Rental revenue is earned from Hawaii Properties and Mainland Properties.
About INMB INmune Bio Inc. Common stock
INmune Bio Inc is a clinical-stage biotechnology company. It is engaged in the development of new immunotherapies that reprogram a patient's innate immune system to allow immune system to fight cancer. The company's pipeline products includeINKmune, INBO3, XPro1595, LIVNate, and others.